Bio-Interaction
GenScript Expands Manufacturing Facility in Zhenjiang, China, to Meet Growing Demand for Oligos and Peptides in APAC Region and Support Advancements in Biopharma
Could you provide some insights into the motivation behind the expansion of GenScript's primary manufacturing facility in Zhenjiang, China, and how...
July 10, 2023 | News
Waters Corporation and Sartorius Collaborate to Address Cost Reduction and Productivity Challenges in BioPharma Bioprocessing
Building on the success of this initial partnership, on June 4, 2023, Waters and Sartorius announced a new phase of their joint efforts. This time, the col...
July 03, 2023 | News
Gilead Sciences Singapore Discusses Access and Affordability of CAR T-Cell Therapy in Singapore and Beyond
Can you elaborate on the current availability and accessibility of CAR T-cell therapies in Singapore? What are the key considerations or barriers that need...
June 19, 2023 | News
Cytiva's BioChallenge Empowers Southeast Asian Biotech Startups to Advance Therapeutic Innovations
In an exclusive interview, Prem Mandalapu, General Manager, Commercial, ASEAN at Cytiva, sheds light on Cytiva's BioChallenge and its objective of supporti...
June 15, 2023 | Influencers
Biotage CEO Discusses Astrea Bioseparations Acquisition and Expansion into Biopharma Sector
BioPharma APAC in an interaction with Tomas Blomquist, CEO and President of Biotage, to gain insights into the recent acquisition of Astrea Biosepara...
June 07, 2023 | News
Thermo Fisher Scientific Expands Sterile Drug Facility in Singapore, Strengthening Asia-Pacific BioPharma Market
Thermo Fisher Scientific, a global leader in serving science, announces the expansion of its sterile drug facility in Singapore, marking a significant mile...
June 02, 2023 | Influencers
Isabelle Lafosse-Marin Discusses Thermo Fisher Scientific's French Expansion, Ushering in a New Era of Drug Manufacturing Excellence.
Isabelle Lafosse-Marin, Senior Director and General Manager of Thermo Fisher Scientific's Bourgoin site, shed light on the company's expansion in Fra...
May 19, 2023 | News
Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities
What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...
May 17, 2023 | News
Cytiva and Pall Life Sciences merge to form a comprehensive solutions provider for biotechnology challenges, with focus on innovation and digitalization
Discover how the combined technical expertise, talent, and portfolio offerings of these two distinguished brands are driving the next generation of medicin...
May 12, 2023 | News
Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs
Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA? The Novel Trial Design initiative at IQ...
May 09, 2023 | News
Emmes' Acquisition of Essex Management Boosts Its Technology Prowess to Help Solve Global Health Challenges
Biopharma APAC sat down with Matt Honan (MH), Vice president and global head of corporate development at Emmes and Ching Tian (CT), Chief In...
April 06, 2023 | Influencers
Podcast : Getting ÄKTA ready in virtual reality
Conor and Dodi try their hand at learning to operate an ÄKTA ready in virtual reality. Their virtual journey takes them to Singapore and Miami, withou...
April 05, 2023 | Opinion
Noxopharm CEO Discusses SOF-VAC™, a Promising Vaccine Enhancer for mRNA Vaccines
In an interaction with BioPharma APAC, Noxopharm CEO Dr. Gisela Mautner discussed the company's newly announced proprietary product candidate, SOF-VAC&trad...
March 31, 2023 | Influencers
Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows
Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...
March 29, 2023 | Influencers
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
